502 related articles for article (PubMed ID: 32939323)
1. Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.
Li B; Zhang B; Wang X; Zeng Z; Huang Z; Zhang L; Wei F; Ren X; Yang L
Oncoimmunology; 2020 Aug; 9(1):1807291. PubMed ID: 32939323
[TBL] [Abstract][Full Text] [Related]
2. Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma.
Qi L; Jiang K; Zhao FF; Ren P; Wang L
Sci Rep; 2024 Jan; 14(1):577. PubMed ID: 38182638
[TBL] [Abstract][Full Text] [Related]
3. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
4. Dynamic change in Siglec-15 expression in peritumoral macrophages confers an immunosuppressive microenvironment and poor outcome in glioma.
Chen Q; Chen B; Wang C; Hu L; Wu Q; Zhu Y; Zhang Q
Front Immunol; 2023; 14():1159085. PubMed ID: 37234161
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients.
Fudaba H; Momii Y; Hirakawa T; Onishi K; Asou D; Matsushita W; Kawasaki Y; Sugita K; Fujiki M
Sci Rep; 2021 Jan; 11(1):1206. PubMed ID: 33441719
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.
Cui L; Tian X; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wu J; Hao C
Int J Med Sci; 2022; 19(13):1977-1988. PubMed ID: 36438917
[No Abstract] [Full Text] [Related]
7. Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma.
Zhao J; Yang H; Hu H; Liu C; Wei M; Zhao Y; Chen Y; Cui Y; Chen P; Xiong K; Lu Y; Yang H; Yang L
Sci Rep; 2022 Jun; 12(1):10401. PubMed ID: 35729260
[TBL] [Abstract][Full Text] [Related]
8. Molecular structure, expression, and the emerging role of Siglec-15 in skeletal biology and cancer.
Rashid S; Song D; Yuan J; Mullin BH; Xu J
J Cell Physiol; 2022 Mar; 237(3):1711-1719. PubMed ID: 34893976
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a novel immune checkpoint, Siglec-15, in pancreatic ductal adenocarcinoma.
Chen X; Mo S; Zhang Y; Ma H; Lu Z; Yu S; Chen J
J Pathol Clin Res; 2022 May; 8(3):268-278. PubMed ID: 35083884
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of Siglec family genes in cutaneous melanoma.
Li K; Xu N; Guo S
Front Immunol; 2023; 14():1036019. PubMed ID: 37207210
[TBL] [Abstract][Full Text] [Related]
11. Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation.
Chen Z; Yu M; Guo L; Zhang B; Liu S; Zhang W; Zhou B; Yan J; Ma Q; Yang Z; Xiao Y; Xu Y; Li H; Ye Q
Front Oncol; 2020; 10():586820. PubMed ID: 33240817
[TBL] [Abstract][Full Text] [Related]
12. The significance of Siglec-15 expression in resectable non-small cell lung cancer.
Hao JQ; Nong JY; Zhao D; Li HY; Su D; Zhou LJ; Dong YJ; Zhang C; Che NY; Zhang SC; Lin JZ; Yang JB; Zhang HT; Wang JH
Neoplasma; 2020 Nov; 67(6):1214-1222. PubMed ID: 32749846
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-Assisted Blockade of the Immune Suppressor Sialic Acid-Binding Immunoglobulin-Like Lectin-15 for Cancer Immunotherapy.
Wu Q; Wei X; Chen F; Huang M; Zhang S; Zhu L; Zhou L; Yang C; Song Y
Angew Chem Int Ed Engl; 2023 Dec; 62(52):e202312609. PubMed ID: 37955317
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
Shi H; Gao L; Zhang W; Jiang M
BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
[TBL] [Abstract][Full Text] [Related]
15. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway.
Li H; Zhu R; Liu X; Zhao K; Hong D
Oxid Med Cell Longev; 2022; 2022():3341038. PubMed ID: 36105484
[TBL] [Abstract][Full Text] [Related]
16. Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas.
Li B; Guo Y; Yi Y; Huang Z; Ren Y; Wang H; Yang L
J Transl Med; 2023 Sep; 21(1):599. PubMed ID: 37674198
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
Ren X; Ji Y; Jiang X; Qi X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining.
Zhang H; Xie Y; Hu Z; Yu H; Xie X; Ye Y; Xu W; Nian S; Yuan Q
Front Oncol; 2021; 11():608113. PubMed ID: 33796453
[No Abstract] [Full Text] [Related]
19. Blocking siglec-10
Xiao N; Zhu X; Li K; Chen Y; Liu X; Xu B; Lei M; Xu J; Sun HC
Exp Hematol Oncol; 2021 Jun; 10(1):36. PubMed ID: 34112250
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
